Dr. Nanus on Cytoreductive Nephrectomy for RCC

David M. Nanus, MD
Published: Monday, Aug 28, 2017



David M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses cytoreductive nephrectomy for patients with renal cell carcinoma (RCC).

There have been a number of retrospective analyses comparing patients who have had a cytoreductive nephrectomy versus those who did not, explains Nanus. It was clear that patients who had a cytoreductive nephrectomy experienced a higher response.

According to Nanus, if a person can undergo a cytoreductive nephrectomy they should have one as the procedure is associated with improved survival.
 


David M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses cytoreductive nephrectomy for patients with renal cell carcinoma (RCC).

There have been a number of retrospective analyses comparing patients who have had a cytoreductive nephrectomy versus those who did not, explains Nanus. It was clear that patients who had a cytoreductive nephrectomy experienced a higher response.

According to Nanus, if a person can undergo a cytoreductive nephrectomy they should have one as the procedure is associated with improved survival.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x